Thoracic Aortic Aneurysms Clinical Trial
Official title:
Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies
The purpose of this study is to evaluate the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy will be evaluated by the device-related adverse event rate of endovascular repair (via Relay Thoracic Stent-Graft) through 1-year. Safety will be evaluated by comparing major adverse events through 1-year in subjects treated with the Relay Thoracic Stent-Graft to those who underwent surgical repair. Long term follow-up is conducted through 5 years.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT00583817 -
Endovascular Treatment of Thoracic Aortic Disease
|
N/A | |
Completed |
NCT00597870 -
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
|
N/A | |
Completed |
NCT00604799 -
VALOR: The Talent Thoracic Stent Graft System Clinical Study
|
Phase 2/Phase 3 | |
Recruiting |
NCT03142074 -
Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms
|
||
Completed |
NCT01839695 -
Safety and Efficacy of Valiant Mona LSA Stent Graft System
|
N/A | |
Terminated |
NCT00805948 -
Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
|
N/A |